AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals needs clearance from antitrust authorities from 13 jurisdictions, including the United States, the European Union, the UK, Brasil, South Korea and Japan. Canada, Colombia, Israel, Morocco, Russia, Taiwan and Turkey are also on the list, which was disclosed by the companies in their filing with the